Skip to content
10-Q

Quarterly Report

ARGOS THERAPEUTICS INC

0001171843-18-008023

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 17, 2018 10.59M sh
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$14.65M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$31.51M
Long Term Debt Q3 2018 · Sep 30, 2018 $11.96M
Long Term Debt Q3 2018 · Dec 31, 2017 $12.13M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $7.94M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $15.19M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $9.37M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $52.97M
Stockholders Equity Q3 2018 · Sep 30, 2018 −$12.57M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$9.23M
Current Liabilities Q3 2018 · Sep 30, 2018 $9.37M
Current Liabilities Q3 2018 · Dec 31, 2017 $9.56M
Current Assets Q3 2018 · Sep 30, 2018 $9.04M
Current Assets Q3 2018 · Dec 31, 2017 $17.18M
Total Assets Q3 2018 · Sep 30, 2018 $10.88M
Total Assets Q3 2018 · Dec 31, 2017 $20.78M
Sga Expense Q3 2018 · Sep 30, 2018 $3.02M
Sga Expense Q3 2018 · Sep 30, 2018 $8.01M
Sga Expense Q3 2018 · Sep 30, 2017 $2.88M
Sga Expense Q3 2018 · Sep 30, 2017 $9.52M
Rd Expense Q3 2018 · Sep 30, 2018 $3.32M
Rd Expense Q3 2018 · Sep 30, 2018 $12.79M
Rd Expense Q3 2018 · Sep 30, 2017 $4.55M
Rd Expense Q3 2018 · Sep 30, 2017 $17.59M
Net Income Q3 2018 · Sep 30, 2018 −$5M
Net Income Q3 2018 · Sep 30, 2018 −$13.59M
Net Income Q3 2018 · Sep 30, 2017 −$6.07M
Net Income Q3 2018 · Sep 30, 2017 −$38.68M
Operating Income Q3 2018 · Sep 30, 2018 −$5.09M
Operating Income Q3 2018 · Sep 30, 2018 −$13.57M
Operating Income Q3 2018 · Sep 30, 2017 −$8.05M
Operating Income Q3 2018 · Sep 30, 2017 −$60.11M
Capex Q3 2018 · Sep 30, 2017 $3.67M